Abstract
The Keystone Symposium on Stem Cell Differentiation and Dedifferentiation attracted nearly 500 participants affiliated with academia, the biotechnology industry, scientific publishing and clinical practice. This broad group examined current advances in stem-cell biology, with a particular focus on induced pluripotent stem cells, and discussed both their potential and limitations in therapeutic applications.